EGFR-Targeted Antibody–Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells.

MLA

Pisheh, Leila, et al. “EGFR-Targeted Antibody–Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells.” Cancers, vol. 16, no. 7, Apr. 2024, p. 1256. EBSCOhost, https://doi.org/10.3390/cancers16071256.

APA

Pisheh, L., Matis, S., Taglieri, M., Di Gregorio, L., Benelli, R., & Poggi, A. (2024). EGFR-Targeted Antibody–Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells. Cancers, 16(7), 1256. https://doi.org/10.3390/cancers16071256

Chicago

Pisheh, Leila, Serena Matis, Martina Taglieri, Linda Di Gregorio, Roberto Benelli, and Alessandro Poggi. 2024. “EGFR-Targeted Antibody–Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells.” Cancers 16 (7): 1256. doi:10.3390/cancers16071256.